Literature DB >> 7127772

Liquid-chromatographic determination of cyclosporine in serum with use of a rapid extraction procedure.

G C Yee, D J Gmur, M S Kennedy.   

Abstract

In this procedure, reversed-phase liquid chromatography is used to measure cyclosporine, a fungal metabolite with immunosuppressive activity, in human serum. With a gradient elution, the retention times for cyclosporine and cyclosporin D were 14.1 and 15.7 min, respectively. Ultraviolet absorbance at 215 nm was used to detect cyclosporine; this wavelength improved assay accuracy without decreasing sensitivity, as compared with detection at 205 nm, which is near the absorption maximum. The major advantage of our procedure is the clean-up method, which involves use of disposable extraction columns. This extraction is simple and requires only 10 to 15 min per sample. Results by radioimmunoassay for cyclosporine were unpredictably greater than those measured by the present method. Dosing guidelines for cyclosporine need re-evaluation, based on more specific assay methods.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127772

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.

Authors:  G J Burckart; R Venkataramanan; R J Ptachcinski; T E Starzl; B P Griffith; T R Hakala; J T Rosenthal; R L Hardesty; S Iwatsuki; J Brady
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

Review 2.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

3.  Effect of column temperature and eluent flow rate on the high performance liquid chromatographic analysis of cyclosporin a and d.

Authors:  K A Mereish; C T Ueda
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

4.  Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer.

Authors:  Sonia Trombino; Federica Curcio; Teresa Poerio; Michele Pellegrino; Rossella Russo; Roberta Cassano
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

5.  Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin.

Authors:  Sonia Trombino; Camilla Servidio; Annarita Stella Laganà; Filomena Conforti; Mariangela Marrelli; Roberta Cassano
Journal:  Molecules       Date:  2020-08-02       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.